Dr Thomas Weaver

Chief Executive Officer

Thomas Weaver
Tom enjoys creating value in new projects, particularly early stage companies.  Previous experiences include being a founding scientist in Hexagen Genetics LTD (acquired by Incyte PLC), Geneservice Limited (acquired by Source Bioscience PLC), and Congenica LTD and Next Gen Diagnostics LLC (both still private).

He has more than 20 years of experience in technology development, specializing in genomic based research and drug discovery, as well as commercial expertise in building and managing multifunctional teams and developing business in the EU, USA and China.

Previous academic and government science experience includes having been a Medical Research Council (MRC) Director in Oxford where he managed the UK’s largest mammalian genetic animal R&D infrastructure and was a founding member of the International Mouse Phenotyping Consortium (IMPC), and before that he set up and managed a national genomic service program (part of the MRC human genome project, Hinxton, UK).  He received his BSc in mathematics and biochemistry (University of Wisconsin, Madison), and a PhD in experimental oncology (McArdle Labs, University of Wisconsin Medical School) before moving to the UK where he carried out post-doctoral research at the MRC Lab for Molecular Biology and the University of Cambridge.